Skip to main content
SpringerLink
Log in

Gastrointestinal Disorders

  • Chapter
  • First Online:
Perinatology

  • 1464 Accesses

Abstract

Gastrointestinal disorders are very frequent in pregnancy. Nausea and vomiting occur in nearly 80% of all pregnant women. Pregnancy due to anatomical and functional changes may complicate some gastrointestinal diseases. It is important to understand the normal physiology of gestation in order to offer the best approach to symptoms. Here, we present clinical features and treatment approach to gastroesophageal reflux, nausea, vomiting, and inflammatory bowel disease in pregnant women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Malfertheiner F, et al. A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol. 2012;12:131.

    Google Scholar 

  2. Malfertheiner F, et al. Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study. Eur J Gastroenterol Hepatol. 29;892–6.

    Google Scholar 

  3. Barr W. Heartburn in pregnancy. J Obstet Gynecol Br Emp. 1958;65:1019–21.

    Google Scholar 

  4. Richter JE. Gastroesophageal reflux during pregnancy. Gastroenterol Clin N Am. 2003;32:235–61.

    Google Scholar 

  5. Nagler R, Spiro HM. Heartburn in late pregnancy: manometric studies of esophageal motor function. J Clin Invest. 1961;40:954–70.

    CAS  Google Scholar 

  6. Lind JF, Smith AM, McKiver DK, et al. Heartburn in pregnancy–a manometry study. CMAJ. 1968;98:571–4.

    CAS  Google Scholar 

  7. Ulmsten U, Sundstrom G. Esophageal manometry in pregnant and nonpregnant women. Am J Obstet Gynecol. 1978;132:260–4.

    CAS  Google Scholar 

  8. de Castro LP. Reflux esophagitis as the cause of heartburn in pregnancy. Am J Obstet Gynecol. 1967;98:1–10.

    Google Scholar 

  9. Capell MS. The safety and efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin N Am. 1998;27:37–71.

    Google Scholar 

  10. American Gastroenterological Association Institute Technical Review on the Use of Gastrointestinal Medications in Pregnancy. Gastroenterology. 2006;131:283–311.

    Google Scholar 

  11. Lewis JH, Weingold AB. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol. 1985;80:912–23.

    CAS  Google Scholar 

  12. Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51(4):410–20.

    Google Scholar 

  13. Majithia R, Johnson DA. Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date Drugs. 2012;72(2):171–9.

    CAS  Google Scholar 

  14. O'Brien B, Zhou Q. Variables related to nausea and vomiting during pregnancy. Birth. 1995;22:93–100.

    CAS  Google Scholar 

  15. Boelig RC, Barton SJ, Saccone G, et al. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2018;31(18):2492–505.

    Google Scholar 

  16. Nuangchamnong N, Niebyl J. Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an over- view. Int J Women's Health. 2014;6:401–9.

    CAS  Google Scholar 

  17. Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy—what’s new? Auton Neurosci. 2017;202:62–72.

    Google Scholar 

  18. Depue RH, Ross RK, Bernstein L, et al. Hypermemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol. 1987;156:1137.

    CAS  Google Scholar 

  19. Matthews A, Haas DM, O’Mathuna DP, et al. Interventions for nausea and vomit- ing in early pregnancy. Cochrane Database Syst Rev. 2015;9:CD007575.

    Google Scholar 

  20. Quinla JD, Hill DA. Nausea and vomiting of pregnancy. Am Fam Physician. 2003;68(1):121–8.

    Google Scholar 

  21. Pontius E, Vieth JT. Complications in early pregnancy. Emerg Med Clin North Am. 2019;37(2):219–37.

    Google Scholar 

  22. Malek NZH, Kalok A, Hanafiah ZA, Shah SA, Ismail NAM. Association of transient hyperthyroidism and severity of hyperemesis gravidarum. Horm Mol Biol Clin Investig. 2017;30(3).

    Google Scholar 

  23. Ng QX, Venkatanarayanan N, De Deyn MLZQ, Ho CYX, Mo Y, Yeo WS. A meta-analysis of the association between Helicobacter pylori (H. pylori) infection and hyperemesis gravidarum. Helicobacter. 2018;23(1).

    Google Scholar 

  24. Li L, Li L, Zhou X, Xiao S, Gu H, Zhang G. Helicobacter pylori infection is associated with an increased risk of hyperemesis Gravidarum: a Meta-analysis. Gastroenterol Res Pract. 2015;2015:278905.

    Google Scholar 

  25. Tian R, MacGibbon K, Martin B, et al. Analysis of pre- and post-pregnancy issues in women with hyperemesis gravidarum. Auton Neurosci. 2017;202:73–8.

    Google Scholar 

  26. Vanagunas A. Gastrointestinal complications in pregnancy. Glob Libr Women’s Med. 2008;

    Google Scholar 

  27. Morgan SR, Long L, Johns J, et al. Are early pregnancy complications more com- Mon in women with hyperemesis gravidarum? J Obstet Gynaecol. 2017;37(3):355–7.

    Google Scholar 

  28. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010;363(16):1544–50.

    Google Scholar 

  29. Niemeijer MN, Grooten IJ, Vos N, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol 2014;211(2):150 e1–15.

    Google Scholar 

  30. Anderka M, Mitchell AA, Louik C, et al. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22–30.

    CAS  Google Scholar 

  31. ACOG Practice Bulletin No. 189. Obstetrics & Gynecology. 2018:131(1);e15–e30.

    Google Scholar 

  32. Giugale LE, Young OM, Streitman DC. Iatrogenic Wernicke encephalopathy in a patient with severe hyper- emesis gravidarum. Obstet Gynecol. 2015;125:1150–2.

    Google Scholar 

  33. Sahakian V, Rouse D, Sipes S, et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo controlled study. Obstet Gynecol. 1991;78:33.

    CAS  Google Scholar 

  34. Sridharan K, Sivaramakrishnan G. Interventions for treating hyperemesis gravidarum: a network meta-analysis of randomized clinical trials. J Matern Fetal Neonatal Med. 2020;33(8):1405–11.

    CAS  Google Scholar 

  35. Kaplan YC, Richardson JL, Keskin-Arslan E, Erol-Coskun H, Kennedy D. Use of ondansetron during pregnancy and the risk of major congenital malformations: a systematic review and meta-analysis. Reprod Toxicol. 2019;86:1–13.

    CAS  Google Scholar 

  36. Lavecchia M, Chari R, Campbell S, Ross S. Ondansetron in pregnancy and the risk of congenital malformations: a systematic review. J Obstet Gynaecol Can. 2018;40(7):910–8.

    Google Scholar 

  37. Safari HR, Fassett MJ, Souter IC, Alsulyman OM, Goodwin TM. The efficacy of methylprednisolone in the treatment of hyperemesis gravidarum: a randomized, double-blind, controlled study. Am J Obstet Gynecol. 1998;179(4):921–4.

    CAS  Google Scholar 

  38. Ardizzone S, Bianchi PG. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med. 2002;252(6):475–96.

    CAS  Google Scholar 

  39. Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol Clin. 2003:32(1).

    Google Scholar 

  40. Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.

    Google Scholar 

  41. Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3–25.

    Google Scholar 

  42. Bell SJ, Flanagan EK. Updates in the management of inflammatory bowel disease during pregnancy. Med J Aust. 2019;210(6):276–80.

    Google Scholar 

  43. Mahadevan U, McConnell RA, Chambers CD. Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel disease. Gastroenterology. 2017;152:451–62.

    Google Scholar 

  44. Hashash JG, Kane S. Pregnancy and inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(2):96–102.

    Google Scholar 

  45. Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131(1):283–311.

    Google Scholar 

  46. Natekar A, Pupco A, Bozzo P, Koren G. Safety of azathioprine use during pregnancy. Can Fam Physician. 2011;57(12):1401–2.

    Google Scholar 

  47. Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? Ann Gastroenterol. 2018;31(4):385–94.

    Google Scholar 

  48. Casanova MJ, Chaparro M, Domènech E, et al. Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108(3):433–40.

    CAS  Google Scholar 

  49. Zelinkova Z, van der Ent C, Bruin KF, Dutch Delta IBD Group, et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol. 2013;11(3):318–21.

    CAS  Google Scholar 

  50. Bell SJ, Flanagan EK. Updates in the management of inflammatory bowel disease during pregnancy. Med J Aust. 2019;210(6):276–80.

    Google Scholar 

  51. Nguyen GC, Seow CH, Maxwell C, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150:734–57.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Florianópolis, SC, Brazil

    Mario Julio Franco & Janaína Luz Narciso-Schiavon

Authors
  1. Mario Julio Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janaína Luz Narciso-Schiavon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Maternal and Child Department, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil

    Renato Augusto Moreira de Sá

  2. Federal University of Paraíba, João Pessoa, Paraíba, Brazil

    Eduardo Borges da Fonseca

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Franco, M.J., Narciso-Schiavon, J.L. (2022). Gastrointestinal Disorders. In: Moreira de Sá, R.A., Fonseca, E.B.d. (eds) Perinatology. Springer, Cham. https://doi.org/10.1007/978-3-030-83434-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-83434-0_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-83433-3

  • Online ISBN: 978-3-030-83434-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation